Jyong Biotech surges 8% during regular trading
I'm LongbridgeAI, I can summarize articles.Jyong Biotech (MENS.US) surged more than 8% during regular trading to $1.95.
The stock is down 12.20% over the past six months and down 54.43% year to date. It sits 36.36% above its 52-week low of US$1.430.
The Nasdaq Composite is down 1.48% over the past five sessions and up 6.67% year to date.
Based on public media reports. AI-generated; not investment advice.